June 17, 2026
Study find over 80 percent of students exceed safe screen limits, leading to headaches and mental health issues
The company reports up to 71.2 pounds weight loss at 68 weeks during trial
Wegovy is now helping overweight adults lower their risk of heart attack, stroke, and cardiovascular death
It found that 1 in 10, or roughly 188 million, school-aged children and adolescents have obesity based on the World Health Organization’s criteria
Some doctors are hesitant to prescribe the drug, citing the lack of long-term safety data
The company’s star weight-loss product Wegovy has been overtaken in the US by rival Eli Lilly’s Zepbound
